David J. Arthur, Chief Executive Officer at Salarius Pharmaceuticals, Inc. (SLRX), bought 4,000 shares at $0.90 ($4K) on 2021-08-17, disclosed to the SEC on 2021-08-17.
Open-market purchase of $4k SLRX by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.89 | 2,000 | $2K | 49.7% |
| 2 | $0.90 | 2,000 | $2K | 50.3% |
| Total | $0.90 avg | 4,000 | $4K | 100% |
| Filing → |
| SLRX | BUY | 2020-08-20 | $1K | — | Filing → |
| SLRX | BUY | 2020-02-12 | $3K | — | Filing → |